Swamy model lie exposed: Ministry says Priyanka, Karti have only one DIN

Bengaluru, June 23: A senior IAS officer allegedly, who had faced arrest in connection with I Monetary Advice (IMA) scam, today allegedly committed suicide by hanging himself at his residence in the city. 

The deceased is BM Vijay Shankar. He had been arrested by special investigation team (SIT) in the I Monetary Advice (IMA) case when he was deputy commissioner (DC) Urban Bengaluru. 

He had spent few days in the jail over his alleged involvement in the IMA scam and was released on bail. The IMA case is currently being probed by Central Bureau of Investigation.

Shankar was staying in Jayanagar near Ashoka Pillar along with his family members.

Shankar was accused of taking Rs 1.5 crore to approve a report on financial irregularities, and was accused of giving a clean chit to the main accused of IMA scam, Mohammed Mansoor Khan.

The incident came to light around 8 pm. It is alleged that Shankar ended his life around 7.00 pm, when he was alone in the house. Shankar was said to be under severe depression after his name surfaced in the scam, and his subsequent arrest.

However, the exact reason for his extreme step is yet to be identified. Tilak Nagar police have taken up the case of mysterious death under CrPc and are probing further. As of now the police officials have not found any death note. A senior officer said: "once we finish the procedures of investigating the spot his body will be shifted to Victoria hospital for post mortem. The report will find out exact cause of his death".

Police commissioner Bhaskar Rao said: "We have taken up the case of unnatural death with regard to Vijay Shankar's death. Further probe will reveal more details about it".
 

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.